Lipocine Inc.LPCNNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 16 | 1 | -3 |
| Gross Profit | 8 | -8 | -13 |
| Operating Income | 3 | -12 | -18 |
| Net Income | -1 | -11 | -16 |
| EBITDA | -0 | -11 | -18 |
| EPS Diluted | -0.12 | -2.05 | -3.14 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 3 | 3 | 5 |
| Total Current Assets | 46 | 34 | 23 |
| Total Assets | 52 | 38 | 23 |
| Total Current Liabilities | 6 | 2 | 3 |
| Total Liabilities | 7 | 2 | 3 |
| Total Equity | 46 | 36 | 20 |
| Total Debt | 2 | 0 | 0 |
| Net Debt | -1 | -3 | -5 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -4 | -12 | -12 |
| Capital Expenditure | -0 | -0 | -0 |
| Free Cash Flow | -4 | -12 | -12 |
| Stock-Based Comp | 1 | 1 | 1 |
| Net Change in Cash | -21 | 0 | 2 |